vs
Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and OneStream, Inc. (OS). Click either name above to swap in a different company.
COLLEGIUM PHARMACEUTICAL, INC is the larger business by last-quarter revenue ($205.4M vs $163.7M, roughly 1.3× OneStream, Inc.). COLLEGIUM PHARMACEUTICAL, INC runs the higher net margin — 8.3% vs 0.6%, a 7.6% gap on every dollar of revenue. On growth, OneStream, Inc. posted the faster year-over-year revenue change (23.6% vs 12.9%). COLLEGIUM PHARMACEUTICAL, INC produced more free cash flow last quarter ($122.4M vs $25.6M). Over the past eight quarters, OneStream, Inc.'s revenue compounded faster (21.8% CAGR vs 19.1%).
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.
Blue Stream provides cable television, cable telephone, DVR, and up to 1 GIG Internet speed broadband services to customers in the Florida communities of Coral Springs and Weston.
COLL vs OS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $205.4M | $163.7M |
| Net Profit | $17.0M | $999.0K |
| Gross Margin | 62.5% | 69.8% |
| Operating Margin | 29.6% | -3.2% |
| Net Margin | 8.3% | 0.6% |
| Revenue YoY | 12.9% | 23.6% |
| Net Profit YoY | 35.3% | — |
| EPS (diluted) | $0.48 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $205.4M | $163.7M | ||
| Q3 25 | $209.4M | $154.3M | ||
| Q2 25 | $188.0M | $147.6M | ||
| Q1 25 | $177.8M | $136.3M | ||
| Q4 24 | $181.9M | $132.5M | ||
| Q3 24 | $159.3M | $129.1M | ||
| Q2 24 | $145.3M | $117.5M | ||
| Q1 24 | $144.9M | $110.3M |
| Q4 25 | $17.0M | $999.0K | ||
| Q3 25 | $31.5M | $-8.8M | ||
| Q2 25 | $12.0M | $-18.4M | ||
| Q1 25 | $2.4M | $-24.0M | ||
| Q4 24 | $12.5M | — | ||
| Q3 24 | $9.3M | $-171.9M | ||
| Q2 24 | $19.6M | $-7.8M | ||
| Q1 24 | $27.7M | $-5.0M |
| Q4 25 | 62.5% | 69.8% | ||
| Q3 25 | 61.7% | 68.1% | ||
| Q2 25 | 57.7% | 68.6% | ||
| Q1 25 | 54.8% | 68.0% | ||
| Q4 24 | 54.0% | 66.8% | ||
| Q3 24 | 60.8% | 50.1% | ||
| Q2 24 | 62.5% | 68.5% | ||
| Q1 24 | 63.1% | 69.1% |
| Q4 25 | 29.6% | -3.2% | ||
| Q3 25 | 29.7% | -11.3% | ||
| Q2 25 | 18.7% | -21.8% | ||
| Q1 25 | 12.2% | -29.3% | ||
| Q4 24 | 20.9% | -35.8% | ||
| Q3 24 | 21.9% | -197.6% | ||
| Q2 24 | 32.7% | -9.8% | ||
| Q1 24 | 34.1% | -4.9% |
| Q4 25 | 8.3% | 0.6% | ||
| Q3 25 | 15.0% | -5.7% | ||
| Q2 25 | 6.4% | -12.5% | ||
| Q1 25 | 1.4% | -17.6% | ||
| Q4 24 | 6.9% | — | ||
| Q3 24 | 5.9% | -133.1% | ||
| Q2 24 | 13.5% | -6.7% | ||
| Q1 24 | 19.1% | -4.5% |
| Q4 25 | $0.48 | — | ||
| Q3 25 | $0.84 | — | ||
| Q2 25 | $0.34 | — | ||
| Q1 25 | $0.07 | — | ||
| Q4 24 | $0.36 | — | ||
| Q3 24 | $0.27 | $-1.06 | ||
| Q2 24 | $0.52 | — | ||
| Q1 24 | $0.71 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $386.7M | $693.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $301.7M | $504.7M |
| Total Assets | $1.7B | $1.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $386.7M | $693.6M | ||
| Q3 25 | $285.9M | $653.9M | ||
| Q2 25 | $222.2M | $652.1M | ||
| Q1 25 | $197.8M | $593.9M | ||
| Q4 24 | $162.8M | $544.2M | ||
| Q3 24 | $120.0M | $495.5M | ||
| Q2 24 | $271.6M | $140.5M | ||
| Q1 24 | $318.0M | — |
| Q4 25 | $301.7M | $504.7M | ||
| Q3 25 | $274.8M | $472.1M | ||
| Q2 25 | $232.2M | $458.2M | ||
| Q1 25 | $234.4M | $412.9M | ||
| Q4 24 | $228.8M | $386.2M | ||
| Q3 24 | $234.3M | $458.2M | ||
| Q2 24 | $216.6M | $97.5M | ||
| Q1 24 | $222.2M | $102.5M |
| Q4 25 | $1.7B | $1.0B | ||
| Q3 25 | $1.6B | $949.4M | ||
| Q2 25 | $1.6B | $910.5M | ||
| Q1 25 | $1.6B | $867.3M | ||
| Q4 24 | $1.7B | $823.2M | ||
| Q3 24 | $1.6B | $750.1M | ||
| Q2 24 | $1.1B | $379.7M | ||
| Q1 24 | $1.1B | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $123.0M | $25.8M |
| Free Cash FlowOCF − Capex | $122.4M | $25.6M |
| FCF MarginFCF / Revenue | 59.6% | 15.7% |
| Capex IntensityCapex / Revenue | 0.3% | 0.1% |
| Cash ConversionOCF / Net Profit | 7.25× | 25.79× |
| TTM Free Cash FlowTrailing 4 quarters | $327.6M | $95.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $123.0M | $25.8M | ||
| Q3 25 | $78.4M | $5.0M | ||
| Q2 25 | $72.4M | $29.7M | ||
| Q1 25 | $55.4M | $36.2M | ||
| Q4 24 | $84.6M | — | ||
| Q3 24 | $-9.0M | $2.4M | ||
| Q2 24 | $67.4M | $8.1M | ||
| Q1 24 | $61.9M | $25.5M |
| Q4 25 | $122.4M | $25.6M | ||
| Q3 25 | $78.3M | $4.8M | ||
| Q2 25 | $72.4M | $29.4M | ||
| Q1 25 | $54.6M | $35.8M | ||
| Q4 24 | $84.1M | — | ||
| Q3 24 | $-9.2M | $1.3M | ||
| Q2 24 | $67.1M | $7.7M | ||
| Q1 24 | $61.4M | $24.9M |
| Q4 25 | 59.6% | 15.7% | ||
| Q3 25 | 37.4% | 3.1% | ||
| Q2 25 | 38.5% | 19.9% | ||
| Q1 25 | 30.7% | 26.3% | ||
| Q4 24 | 46.2% | — | ||
| Q3 24 | -5.8% | 1.0% | ||
| Q2 24 | 46.2% | 6.6% | ||
| Q1 24 | 42.3% | 22.5% |
| Q4 25 | 0.3% | 0.1% | ||
| Q3 25 | 0.1% | 0.1% | ||
| Q2 25 | 0.0% | 0.2% | ||
| Q1 25 | 0.4% | 0.3% | ||
| Q4 24 | 0.3% | — | ||
| Q3 24 | 0.2% | 0.8% | ||
| Q2 24 | 0.2% | 0.3% | ||
| Q1 24 | 0.4% | 0.6% |
| Q4 25 | 7.25× | 25.79× | ||
| Q3 25 | 2.49× | — | ||
| Q2 25 | 6.05× | — | ||
| Q1 25 | 22.92× | — | ||
| Q4 24 | 6.75× | — | ||
| Q3 24 | -0.96× | — | ||
| Q2 24 | 3.44× | — | ||
| Q1 24 | 2.23× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
COLL
Segment breakdown not available.
OS
| Subscription And Circulation | $150.3M | 92% |
| Professional Services And Other | $9.4M | 6% |
| License | $4.0M | 2% |
